Sign in
New Treatment Paradigm for Infectious Endophthalmitis: Results from the Mexican Endophthalmitis Study Group Protocol 1 and 3
Raul Velez-Montoya, MD
Updates from the Field
2024
APX3330, an Oral Drug in Trial for DR and DME, Demonstrated a Favorable Safety and Tolerability Profile in Multiple Phase 1 and 2 Studies
Michael J Allingham, MD, PhD
Annual Meeting Talks
2021
Best Corrected Visual Acuity at 36 Months in Study of FAi Insert for NIPU
Sumit Sharma, MD, FASRS
2019
Category: Inflammatory and Infectious Diseases